Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-10-15

FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Original Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a generic fixed-dose combination of irbesartan and hydrochlorothiazide (IRBESARTAN AND HYDROCHLOROTHIAZIDE). The approval was issued under an Origi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IRBESARTAN AND HYDROCHLOROTHIAZIDE (irbesartan and hydrochlorothiazide)

Snippet

ORIG AP for IRBESARTAN AND HYDROCHLOROTHIAZIDE (IRBESARTAN AND HYDROCHLOROTHIAZIDE)